OM DENNE EPISODE

Engelsk
USA

UDSKRIFT 🔗

SØG BLANDT TIDLIGERE EPISODER

Søg efter gamle afsnit af ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research.

ANDRE EPISODE I DENNE PODCAST

The future of cardiovascular health depends on prevention that begins early in life. This episode reviews strategies for recognizing cardiovascular risk at an early stage and implementing interventions that can alter the trajectory of atherosclerotic cardiovascular disease before complications occu…
Nonobstructive hypertrophic cardiomyopathy (HCM) represents one of the greatest areas of unmet need in HCM management. A key question is identifying the primary driver of symptoms in these patients, as many experience significant functional limitations despite the absence of left ventricular outflo…
The VESALIUS-CV trial demonstrated that the PCSK9 inhibitor evolocumab significantly reduced the risk of a first major cardiovascular event in patients with diabetes who had no known significant atherosclerosis. These findings challenge current clinical practice, where PCSK9 inhibitors are typicall…
Randomized trials in stable ischemic heart disease (SIHD) show revascularization does not reduce death or myocardial infarction versus guideline-directed medical therapy, with benefit limited to symptom relief. This likely reflects lesion–ischemia mismatch, unclear ischemia origin, effective modern…
Ansvarsfraskrivelse: Podcasten og kunstværket, der er indlejret på denne side, er fra American College of Cardiology, som tilhører dens ejer og ikke er tilknyttet eller godkendt af Listen Notes, Inc.